Saamya Biotech (India) Limited reported unaudited earnings results for the second quarter and half year ended September 30, 2012. For the quarter, the company reported loss from operations before other income, interest & exceptional items were INR 975,035 against profit from operations before other income, interest & exceptional items of INR 1,468,743 a year ago. Loss from ordinary activities before tax was INR 1,113,396 against profit from ordinary activities before tax of INR 1,363,789 a year ago. Net loss was INR 1,124,596 or INR 0.05 basic and diluted per share against net profit of INR 829,057 or INR 0.03 basic and diluted per share a year ago.

For the half year, the company's net sales were INR 29,824,673 against INR 83,269,560 a year ago. Loss from operations before interest & exceptional items were INR 651,370 against profit from operations before interest & exceptional items of INR 1,977,098 a year ago. Loss from ordinary activities before tax was INR 834,307 against profit from ordinary activities before tax of INR 1,829,028 a year ago. Net loss was INR 939,487 or INR 0.04 basic and diluted per share against INR 1,294,296 or INR 0.05 basic and diluted per share a year ago.